{"meta":{"query_hash":"55965a6cf75c","filters":{"venue":"Asia-Pacific Journal of Clinical Oncology"},"cohort_total":31,"direct_labels_cover":1,"predictions_cover":31,"exported":31,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/55965a6cf75c","api":"https://metacan.xera.ac/api/v1/cohort?venue=Asia-Pacific+Journal+of+Clinical+Oncology"},"results":[{"id":"W1486211631","doi":"10.1111/ajco.12189","title":"Preparing for tomorrow: Molecular diagnostics and the changing nonsmall cell lung cancer landscape","year":2014,"lang":"en","type":"review","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Anaplastic lymphoma kinase; Medicine; Lung cancer; Targeted therapy; Cancer; Oncology; Identification (biology); Precision medicine; Chemotherapy; Internal medicine; Bioinformatics; Intensive care medicine; Cancer research; Pathology; Biology","score_opus":0.04746569454896561,"score_gpt":0.48354004033448117,"score_spread":0.43607434578551557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1486211631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000082193226,0.9844683,0.0018153876,0.0014607761,0.0017127474,0.0015014425,0.000026286187,0.000009373317,0.008923536],"genre_scores_gemma":[0.0017643927,0.9934374,0.001769611,0.0003212049,0.0017311606,0.00020229473,0.000023054841,0.00005574325,0.00069514016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966642,0.0004402558,0.0020318183,0.0002976176,0.0002150159,0.00035104805],"domain_scores_gemma":[0.9905104,0.006386185,0.002243477,0.00028354998,0.00030131626,0.00027507145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025086566,0.0003033292,0.0035520226,0.00019662411,0.00010720516,0.000028643866,0.00019899524,0.00049367285,0.000024990894],"category_scores_gemma":[0.0015548863,0.00016298948,0.0011865683,0.0001580559,0.00020333575,0.00004015834,0.000074758784,0.00085569895,0.0000032267449],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036986562,0.00029229073,0.0005204459,0.004737652,0.002031326,0.00014747873,0.0003043791,0.0000048085476,1.1955954e-7,0.0003973027,0.0074079256,0.9837864],"study_design_scores_gemma":[0.0066989744,0.0011819031,0.00001989251,0.0046772393,0.018714646,0.00045877634,0.00017697937,0.00011430141,7.3453714e-7,0.0000701759,0.9677385,0.00014788834],"about_ca_topic_score_codex":0.0000062912236,"about_ca_topic_score_gemma":0.000009366379,"teacher_disagreement_score":0.9836385,"about_ca_system_score_codex":0.00016939962,"about_ca_system_score_gemma":0.0021886306,"threshold_uncertainty_score":0.6646518},"labels":[],"label_agreement":null},{"id":"W1572964200","doi":"10.1111/ajco.12190","title":"<scp>N</scp>ational <scp>W</scp>orking <scp>G</scp>roup <scp>M</scp>eeting on <scp>ALK</scp> diagnostics in lung cancer","year":2014,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Comprehensive Cancer Network; Royal College of Pathologists of Australasia; Pfizer","keywords":"Lung cancer; Medicine; Cancer research; Oncology","score_opus":0.04332227479013119,"score_gpt":0.4227194851432604,"score_spread":0.37939721035312923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572964200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8147391,0.007605286,0.0016061991,0.0028496068,0.009557327,0.0019138305,0.00021877431,0.00021614823,0.1612937],"genre_scores_gemma":[0.94633156,0.010125963,0.0059053097,0.005176106,0.011695621,0.00034685386,0.0003134915,0.00043594206,0.019669177],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.98394364,0.0021097185,0.00666403,0.0019026527,0.0025671357,0.0028128373],"domain_scores_gemma":[0.8962157,0.09295135,0.0056087626,0.0012377447,0.0018436211,0.0021428436],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.007262462,0.0015288016,0.004426342,0.0014823374,0.0007629774,0.00029261585,0.0013022827,0.0021777262,0.00006537328],"category_scores_gemma":[0.101479985,0.0013353411,0.001686401,0.0016940433,0.0010281716,0.00077489816,0.00040778017,0.005367385,0.00034092946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009856663,0.0066468073,0.5189273,0.00045712135,0.0036661706,0.0024684588,0.009510728,0.0028590653,0.0005157632,0.0032529784,0.41860765,0.032989394],"study_design_scores_gemma":[0.015432088,0.0060740625,0.19181027,0.0019147466,0.0027437091,0.0007662354,0.013701006,0.0017633261,0.0005425777,0.0017718063,0.76334345,0.00013669938],"about_ca_topic_score_codex":0.00025039547,"about_ca_topic_score_gemma":0.00056037324,"teacher_disagreement_score":0.3447358,"about_ca_system_score_codex":0.0022831562,"about_ca_system_score_gemma":0.004965052,"threshold_uncertainty_score":0.9997461},"labels":[],"label_agreement":null},{"id":"W1578512802","doi":"10.1111/ajco.12275","title":"Welcome Message from Conference Co‐Convenors","year":2014,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Theme (computing); Library science; Executive director; Officer; Political science; Media studies; Management; Sociology; Law","score_opus":0.0640635115139888,"score_gpt":0.40288290812288025,"score_spread":0.33881939660889143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1578512802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89178234,0.0009631618,0.014111531,0.0053934553,0.0029073777,0.00013173146,0.000040175597,0.00000928474,0.084660925],"genre_scores_gemma":[0.9934917,0.0010334858,0.0017507268,0.00048837636,0.0020570601,0.000004408136,0.000031695738,0.000017481809,0.0011250708],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974032,0.00058634824,0.0012986449,0.00028909557,0.00019275842,0.00022996089],"domain_scores_gemma":[0.99766713,0.0003153985,0.0010143076,0.0004159588,0.0003199225,0.00026728067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018252686,0.00015016693,0.0006378347,0.000050459807,0.00006089378,0.00002372274,0.00046394538,0.00043105634,0.00036686243],"category_scores_gemma":[0.0008109739,0.00012181772,0.0003257549,0.00006289757,0.00031809454,0.00000963674,0.00005304713,0.00046510156,0.00005173889],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022792732,0.0017913284,0.06736063,0.000020685522,0.0012599123,0.00008620197,0.00024831144,0.00006892014,0.12561864,0.005028749,0.13124266,0.66499466],"study_design_scores_gemma":[0.0019902836,0.0024059508,0.030152537,0.000017592214,0.000081370345,0.000052016054,0.00032754938,0.00005206324,0.005270995,0.0012913219,0.9581867,0.0001716192],"about_ca_topic_score_codex":0.000011118906,"about_ca_topic_score_gemma":0.000017557159,"teacher_disagreement_score":0.82694405,"about_ca_system_score_codex":0.000023290046,"about_ca_system_score_gemma":0.0005669607,"threshold_uncertainty_score":0.49675825},"labels":[],"label_agreement":null},{"id":"W1595251153","doi":"10.1111/j.1743-7563.2010.01328.x","title":"A phase II trial of weekly i.v. KW‐2170 in advanced castrate‐resistant prostate cancer","year":2010,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Neutropenia; Prostate cancer; Internal medicine; Phases of clinical research; Nausea; Oncology; Chemotherapy; Cancer; Gastroenterology; Urology","score_opus":0.09392100312257858,"score_gpt":0.5098557369329367,"score_spread":0.41593473381035817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1595251153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97789735,0.00075457414,0.0000044857898,0.011250768,0.0025556928,0.00092241255,0.00003651103,0.000008641036,0.00656958],"genre_scores_gemma":[0.9925124,0.0025890756,0.0012165138,0.00007958675,0.0009255174,0.00004033639,0.000008101779,0.000026966187,0.0026014969],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99545234,0.00035581095,0.002804687,0.00031489573,0.0005625497,0.00050969515],"domain_scores_gemma":[0.9961854,0.00084846624,0.0014710942,0.0003141893,0.0006663813,0.0005144309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032360624,0.00021951245,0.0017621699,0.00032084688,0.00006178414,0.000009820842,0.00023760271,0.0004245823,0.00036359823],"category_scores_gemma":[0.0013871486,0.00014881302,0.00046597602,0.0003875987,0.00059758895,0.00016458853,0.00006294738,0.002104893,0.0000074163045],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54060435,0.018344834,0.009668593,0.00009061849,0.00047137387,0.00266016,0.00068234315,0.0000053573053,0.046625853,0.00011095525,0.002649487,0.3780861],"study_design_scores_gemma":[0.6232749,0.18176898,0.013184304,0.00043358625,0.0004327531,0.00036695215,0.0021297522,0.000051098956,0.0079032965,0.000769789,0.16940816,0.00027641462],"about_ca_topic_score_codex":0.000056267196,"about_ca_topic_score_gemma":0.00034932772,"teacher_disagreement_score":0.37780967,"about_ca_system_score_codex":0.0001850162,"about_ca_system_score_gemma":0.0050445725,"threshold_uncertainty_score":0.9144831},"labels":[],"label_agreement":null},{"id":"W1706038533","doi":"10.1111/ajco.12064","title":"Comparison of the <scp>EORTC QLQ</scp>‐<scp>BM22</scp> and the <scp>BOMET‐QOL</scp> quality of life questionnaires in patients with bone metastases","year":2013,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Response Biomedical (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Quality of life (healthcare); Medicine; Physical therapy; Reliability (semiconductor); Cancer; Internal medicine; Nursing","score_opus":0.06566616173151467,"score_gpt":0.402386003649203,"score_spread":0.33671984191768833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1706038533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886844,0.001916313,0.00027345069,0.0024503602,0.0007124553,0.0016877215,0.00004934609,0.000017469894,0.004208467],"genre_scores_gemma":[0.9957414,0.00032942,0.0022067993,0.0008177326,0.00020375235,0.0000397631,0.000020581734,0.00004422694,0.00059627555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9868571,0.004634013,0.0056765955,0.00049725885,0.0017172684,0.0006177376],"domain_scores_gemma":[0.9622958,0.02643684,0.0077943155,0.0010777884,0.0015703706,0.0008249216],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0108942,0.00046120645,0.003771276,0.00041193137,0.00012117343,0.000045529763,0.00064911944,0.0003332409,0.00004446987],"category_scores_gemma":[0.058741223,0.0002496396,0.0007240533,0.0007209029,0.0023690672,0.00033916632,0.0002955936,0.0015086773,0.000018107812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005581182,0.0059454213,0.9409527,0.00034094564,0.0012867926,0.000031909534,0.0015393916,0.00003913064,0.000030984895,0.0011727919,0.039193977,0.008907836],"study_design_scores_gemma":[0.021072632,0.0045822705,0.9437054,0.00039527295,0.0014296158,0.000022319859,0.011992132,0.00014411412,0.00006955355,0.0015688654,0.014975906,0.000041951138],"about_ca_topic_score_codex":0.00018192366,"about_ca_topic_score_gemma":0.0000877253,"teacher_disagreement_score":0.04784702,"about_ca_system_score_codex":0.000094048984,"about_ca_system_score_gemma":0.0010386995,"threshold_uncertainty_score":0.9999956},"labels":[],"label_agreement":null},{"id":"W1944351704","doi":"10.1111/ajco.12069","title":"Minimal important differences in the <scp>EORTC QLQ</scp>‐<scp>C15</scp>‐<scp>PAL</scp> to determine meaningful change in palliative advanced cancer patients","year":2013,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Response Biomedical (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Ofelia Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Quality of life (healthcare); Clinical trial; Palliative care; Minimal clinically important difference; Cancer; Breast cancer; Lung cancer; Prostate cancer; Physical therapy; Oncology; Internal medicine; Randomized controlled trial","score_opus":0.08937025942784335,"score_gpt":0.39433845725742894,"score_spread":0.3049681978295856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1944351704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98421544,0.0020426018,0.000018283123,0.0024167323,0.003486326,0.0016313927,0.000071622315,0.000026944763,0.0060906564],"genre_scores_gemma":[0.9903085,0.0028619305,0.00040567404,0.0034343062,0.0017655593,0.00040893635,0.000027351245,0.000071503164,0.00071622327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9910298,0.0013044125,0.004218011,0.00084195175,0.0012870713,0.0013187471],"domain_scores_gemma":[0.9821707,0.012560239,0.002729378,0.00058610627,0.0010111543,0.00094243814],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003381106,0.00066530274,0.0028339038,0.00059248746,0.00011070744,0.000074099655,0.0009410155,0.000801145,0.000092648814],"category_scores_gemma":[0.012950828,0.00045127096,0.0006958971,0.0010723637,0.00041677774,0.0004494903,0.0002087715,0.00251724,0.000069037815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001816029,0.001624696,0.91956055,0.00007077051,0.00021325465,0.00063711754,0.023190644,0.0000030184915,0.00018022313,0.00003812821,0.008433595,0.045866393],"study_design_scores_gemma":[0.006721434,0.010452772,0.8656313,0.0005812144,0.00022918695,0.000080339094,0.03548962,0.00007879466,0.0001503105,0.00031973585,0.08017735,0.000087930304],"about_ca_topic_score_codex":0.0007786739,"about_ca_topic_score_gemma":0.009733537,"teacher_disagreement_score":0.07174376,"about_ca_system_score_codex":0.00051002053,"about_ca_system_score_gemma":0.0010642342,"threshold_uncertainty_score":0.9997939},"labels":[],"label_agreement":null},{"id":"W1962829821","doi":"10.1111/ajco.12070","title":"Minimal important differences in the <scp>EORTC QLQ‐C30</scp> in patients with advanced cancer","year":2013,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Response Biomedical (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Quality of life (healthcare); Medicine; Cancer; Statistical significance; Sample size determination; Physical therapy; Clinical significance; Cognition; Internal medicine; Statistics; Psychiatry; Nursing","score_opus":0.03847075478638437,"score_gpt":0.3653413403519545,"score_spread":0.32687058556557014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1962829821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874433,0.0008358005,0.0000056557446,0.004052052,0.0012262701,0.0004920985,0.000007887197,0.000006180787,0.0059307087],"genre_scores_gemma":[0.997272,0.0007594225,0.00019447155,0.0010215279,0.00043274128,0.000045782966,0.000005203467,0.000019006427,0.0002498502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960596,0.00049848156,0.0021066281,0.00028290783,0.0006041747,0.0004482267],"domain_scores_gemma":[0.99578065,0.0020504824,0.001215145,0.00027385468,0.0004124395,0.00026744633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016790511,0.00021885072,0.0013043531,0.00018739038,0.000032450607,0.000020964391,0.00033303455,0.00030081542,0.000159831],"category_scores_gemma":[0.0010414243,0.00011767904,0.0002386504,0.00039368687,0.00029446257,0.00019191728,0.00003601705,0.0013784001,0.000011750451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076430175,0.0010288431,0.93259275,0.000016943126,0.00008161934,0.00020303494,0.001444934,0.0000013747571,0.000008898018,0.0000320015,0.0018646664,0.06196066],"study_design_scores_gemma":[0.00726681,0.007701176,0.9542026,0.00019189321,0.00009206618,0.000050071798,0.009159153,0.0000090247195,0.000008073665,0.00017305903,0.021086346,0.00005971564],"about_ca_topic_score_codex":0.00045236107,"about_ca_topic_score_gemma":0.003779637,"teacher_disagreement_score":0.061900944,"about_ca_system_score_codex":0.00015792805,"about_ca_system_score_gemma":0.0010174356,"threshold_uncertainty_score":0.59885395},"labels":[],"label_agreement":null},{"id":"W2440371401","doi":"10.1111/ajco.12513","title":"An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non–small cell lung cancer","year":2016,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Pemetrexed; Medicine; Cisplatin; Hazard ratio; Etoposide; Internal medicine; Oncology; Carboplatin; Chemotherapy; Confidence interval; Surgery","score_opus":0.034623184524547664,"score_gpt":0.4324831263084926,"score_spread":0.39785994178394496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2440371401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924435,0.0012019295,0.0011452937,0.0032823829,0.00023167003,0.0014286259,0.000055263274,0.0000064004957,0.00020493119],"genre_scores_gemma":[0.98967254,0.008388663,0.0014605691,0.0001292842,0.00014403989,0.000068546855,0.00002381853,0.000026435084,0.00008607562],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960456,0.00049210835,0.0024499116,0.00040357525,0.00034643942,0.00026237583],"domain_scores_gemma":[0.99534285,0.0012298338,0.0025157903,0.0002644633,0.00034339027,0.0003036856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018161118,0.00025945276,0.0021918723,0.00048631305,0.000037956048,0.000012621959,0.00011789561,0.00034686585,0.000114744085],"category_scores_gemma":[0.00028292992,0.000160383,0.00031081014,0.00058141066,0.00023992093,0.0001936146,0.000014021232,0.0002945246,2.3032528e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2577731,0.0051908814,0.15052736,0.000083868945,0.0017227394,0.00007802288,0.0013824876,0.0000225076,0.017139731,0.000005904697,0.00028396942,0.5657894],"study_design_scores_gemma":[0.7843654,0.071677476,0.110825196,0.0008845569,0.0060191145,0.00006302776,0.001981855,0.003679918,0.018620212,0.0000349746,0.0013730384,0.00047522533],"about_ca_topic_score_codex":0.00008654181,"about_ca_topic_score_gemma":0.0006843645,"teacher_disagreement_score":0.5653142,"about_ca_system_score_codex":0.00036760987,"about_ca_system_score_gemma":0.0013274496,"threshold_uncertainty_score":0.6540229},"labels":[],"label_agreement":null},{"id":"W2531395888","doi":"10.1111/ajco.12524","title":"Convenor's Welcome","year":2016,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mentorship; Medical education; Oncology; Library science","score_opus":0.08744800783826183,"score_gpt":0.43538723783270594,"score_spread":0.3479392299944441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531395888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74201596,0.0022838097,0.00095567346,0.15941672,0.0102174375,0.00033287247,0.000010096854,0.000040225015,0.084727205],"genre_scores_gemma":[0.98804885,0.0026176448,0.0011349515,0.0014776409,0.002047966,0.0000018690253,6.951388e-7,0.000019276791,0.0046510766],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99684227,0.00031852498,0.0020796233,0.00018012885,0.00030478026,0.00027468504],"domain_scores_gemma":[0.9962842,0.0016193873,0.0011622418,0.00026699383,0.00032709324,0.00034007613],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003196496,0.00013582385,0.0010959368,0.00013312908,0.000034643814,0.0000067607752,0.00019668206,0.0003542131,0.0013246634],"category_scores_gemma":[0.0011172721,0.00007204447,0.0007187733,0.0001389668,0.00049704843,0.000108303866,0.000027286798,0.0004853036,0.00014634461],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017196009,0.0009099102,0.06757361,0.0000151598,0.0007780026,0.0007827434,0.00006710589,4.8712163e-8,0.007626378,0.00028622232,0.056893717,0.8478711],"study_design_scores_gemma":[0.012931266,0.008909258,0.10353103,0.00015639505,0.00015048406,0.0017888568,0.00023430403,7.5713683e-7,0.0007080889,0.00048843276,0.8710032,0.00009790286],"about_ca_topic_score_codex":0.00000441385,"about_ca_topic_score_gemma":0.0000049275386,"teacher_disagreement_score":0.8477732,"about_ca_system_score_codex":0.00016366031,"about_ca_system_score_gemma":0.001186266,"threshold_uncertainty_score":0.99958825},"labels":[],"label_agreement":null},{"id":"W2588872717","doi":"10.1111/ajco.12670","title":"Sunrise in melanoma management: Time to focus on melanoma burden in Asia","year":2017,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Melanoma; Focus (optics); Sunrise; Geography; Medicine; Cancer research; Meteorology","score_opus":0.04609936240638862,"score_gpt":0.3855619401874746,"score_spread":0.33946257778108596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588872717","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43791118,0.00007383276,0.0000409271,0.035105977,0.0014098228,0.00074778,0.0000026197997,0.000020810043,0.52468705],"genre_scores_gemma":[0.9790389,0.00022910308,0.0010944963,0.0005350282,0.0008616511,0.000015613781,0.000001747848,0.000035093835,0.018188369],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959438,0.00035157762,0.0022621525,0.0004464709,0.00049956335,0.0004964497],"domain_scores_gemma":[0.9968489,0.00054416066,0.0011725891,0.0007928032,0.00013029574,0.00051124906],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033389572,0.00026414226,0.001513775,0.0008346487,0.00009290552,0.000055915756,0.0005819621,0.00038043145,0.0008705403],"category_scores_gemma":[0.0013287371,0.00022235762,0.00038611094,0.00021315576,0.0001547632,0.00012516583,0.00020976982,0.0011165087,0.0013953047],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012158787,0.002420017,0.039774008,0.00005737582,0.0005506158,0.037987255,0.00034369424,0.000056343782,0.00020812672,0.0014844415,0.021733701,0.8832256],"study_design_scores_gemma":[0.012541389,0.013460798,0.33749524,0.00041475834,0.0002285386,0.0015731901,0.0010495398,0.00011819052,0.000104661114,0.0011435369,0.63156646,0.00030367394],"about_ca_topic_score_codex":0.000062229876,"about_ca_topic_score_gemma":0.00025658833,"teacher_disagreement_score":0.88292193,"about_ca_system_score_codex":0.00039463796,"about_ca_system_score_gemma":0.00022400332,"threshold_uncertainty_score":0.9993822},"labels":[],"label_agreement":null},{"id":"W2789982459","doi":"10.1111/ajco.12855","title":"Cultural adaptation and validation of the Chinese version of the expanded prostate cancer index composite","year":2018,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Adaptation (eye); Prostate cancer; Index (typography); Composite index; Composite number; Cancer; Psychology; Medicine; Computer science; Mathematics; Internal medicine; Composite indicator; Econometrics; Neuroscience; Algorithm; World Wide Web","score_opus":0.05417021280253508,"score_gpt":0.4141333786232248,"score_spread":0.3599631658206897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789982459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896467,0.00048217943,0.0000119869,0.0077209766,0.0010721759,0.00030800776,0.00001248361,0.000002054169,0.0007434598],"genre_scores_gemma":[0.9979471,0.0013566071,0.00017708936,0.00014219606,0.0002715818,0.0000049294986,0.0000024546382,0.0000060802354,0.000091938506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983121,0.00027302327,0.00093644735,0.000110309324,0.00026740288,0.000100704616],"domain_scores_gemma":[0.9973865,0.00034828155,0.0014085354,0.00015483986,0.0006228445,0.00007897417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006645026,0.00009235755,0.00052271807,0.000035542354,0.00006206596,0.000005028742,0.000101554615,0.00011295172,0.000029362729],"category_scores_gemma":[0.00033126143,0.00004023729,0.00020657781,0.00017672068,0.0004852465,0.00009460029,0.00005097954,0.00025818704,8.662214e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021743854,0.0004290725,0.94852567,0.000028496012,0.00021443839,0.0000041204453,0.0015337915,0.0000290101,0.0024420924,0.00001783514,0.00083790463,0.043763205],"study_design_scores_gemma":[0.0052893013,0.0031151408,0.97485936,0.00029249227,0.00029716763,0.00006457212,0.0009446797,0.0001250052,0.011481416,0.00024671902,0.0032411942,0.00004293977],"about_ca_topic_score_codex":0.00005339392,"about_ca_topic_score_gemma":0.000041784955,"teacher_disagreement_score":0.043720268,"about_ca_system_score_codex":0.00009430665,"about_ca_system_score_gemma":0.00044617354,"threshold_uncertainty_score":0.17879109},"labels":[],"label_agreement":null},{"id":"W2895166167","doi":"10.1111/ajco.13065","title":"Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2‐non‐amplified metastatic breast cancer","year":2018,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Metastatic breast cancer; Breast cancer; Cyclin-dependent kinase 4; Palbociclib; Medicine; Context (archaeology); Oncology; Hormone receptor; Cancer; Internal medicine; Human Epidermal Growth Factor Receptor 2; Endocrine system; Cancer research; Hormone; Cell cycle; Biology; Cyclin-dependent kinase 2","score_opus":0.04894483337038611,"score_gpt":0.4177188545871236,"score_spread":0.36877402121673747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895166167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650449,0.0051575718,0.0029205673,0.019893449,0.002950741,0.0015396795,0.001988202,0.000023292996,0.00048160125],"genre_scores_gemma":[0.9588398,0.0050009578,0.030228926,0.00021838251,0.005297036,0.000043848973,0.00010899388,0.000061296894,0.00020081202],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997646,0.0001714905,0.0012738486,0.0003560576,0.00027082372,0.00028181454],"domain_scores_gemma":[0.99605334,0.00071671535,0.0013964905,0.00036318798,0.0011722869,0.00029799348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005625828,0.00023027237,0.0013326918,0.00013643302,0.00010616308,0.000008399346,0.00014570054,0.00014709213,0.00009735394],"category_scores_gemma":[0.00013847077,0.00014804339,0.00016507643,0.00021219761,0.0005611424,0.00024457055,0.00004174935,0.00026129695,0.0000019221598],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031592075,0.0027558818,0.031076862,0.000035514742,0.0022866558,0.000018105911,0.0012085258,9.3001177e-7,0.00047799514,0.000019722007,0.0013163344,0.9292114],"study_design_scores_gemma":[0.028838402,0.038866002,0.38192356,0.0002757824,0.0017706224,0.0003306003,0.0040873024,0.000041787156,0.0003548801,0.000110270856,0.5431527,0.00024810564],"about_ca_topic_score_codex":0.000026878604,"about_ca_topic_score_gemma":0.000057523164,"teacher_disagreement_score":0.9289633,"about_ca_system_score_codex":0.00023999544,"about_ca_system_score_gemma":0.0007669813,"threshold_uncertainty_score":0.60370344},"labels":[],"label_agreement":null},{"id":"W2895682835","doi":"10.1111/ajco.13064","title":"Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm","year":2018,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"Novartis Australia","keywords":"Metastatic breast cancer; Tolerability; Medicine; Oncology; Breast cancer; Internal medicine; Endocrine system; Hormone receptor; Cyclin-dependent kinase; Hormone; Cancer; Cell cycle; Adverse effect","score_opus":0.07353694004946239,"score_gpt":0.4576646807170495,"score_spread":0.38412774066758715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895682835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96262217,0.0029217694,0.00020149937,0.028816132,0.0022876759,0.00084222725,0.0002666219,0.00001919828,0.0020227008],"genre_scores_gemma":[0.9932332,0.0029398866,0.0009093665,0.00023017313,0.0025062363,0.000024567047,0.0000052824407,0.00004110247,0.00011016603],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9956744,0.0009182644,0.002121757,0.00032708322,0.00051370653,0.0004447942],"domain_scores_gemma":[0.9927989,0.0030124462,0.0025429993,0.00039456473,0.0007937507,0.0004573241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013655958,0.0003693286,0.0018942928,0.00018362926,0.00010389094,0.00001126157,0.00024423146,0.00015176654,0.00047349048],"category_scores_gemma":[0.0005868984,0.00019108027,0.0010289946,0.00038274456,0.0013740305,0.0001572551,0.00003560613,0.00095595716,0.000048260983],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0281242,0.004142674,0.013463925,0.000014906539,0.0035886937,0.00009401977,0.001486126,0.000026662367,0.0010940142,0.0002814352,0.0053085126,0.9423748],"study_design_scores_gemma":[0.03088146,0.16626121,0.684053,0.0014934381,0.0025065544,0.0022686606,0.0032610681,0.00008225055,0.006289011,0.004339934,0.09792505,0.0006383245],"about_ca_topic_score_codex":0.00013760425,"about_ca_topic_score_gemma":0.00003514935,"teacher_disagreement_score":0.9417365,"about_ca_system_score_codex":0.0012327188,"about_ca_system_score_gemma":0.0025678403,"threshold_uncertainty_score":0.7792027},"labels":[],"label_agreement":null},{"id":"W2902348306","doi":"10.1111/ajco.13059","title":"Prime time for immunotherapy in advanced urothelial cancer","year":2018,"lang":"en","type":"review","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Carboplatin; Oncology; Internal medicine; Clinical trial; Chemotherapy; Disease; Cisplatin; Immunotherapy; Cancer; Intensive care medicine","score_opus":0.13085102567069737,"score_gpt":0.5175727264392097,"score_spread":0.3867217007685123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902348306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009621189,0.9864908,0.00006801769,0.0009403688,0.0038256936,0.0021875696,0.00012153964,0.000017460547,0.006252372],"genre_scores_gemma":[0.00005693485,0.9869514,0.0029733672,0.0003394667,0.00484385,0.0002024003,0.000027952969,0.00013625425,0.0044683754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931754,0.0007079555,0.004618569,0.0005435021,0.0003887359,0.000565866],"domain_scores_gemma":[0.9931852,0.002072549,0.003363538,0.0004925726,0.0005147053,0.0003713978],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0026258978,0.0005600483,0.007224597,0.00039229525,0.00005066441,0.000015802489,0.0004556625,0.0013037401,0.0007217655],"category_scores_gemma":[0.0008252143,0.0003780744,0.0025231186,0.0003123584,0.00033802987,0.000107901455,0.000042591535,0.001492163,0.00016063362],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042284103,0.0011925258,0.00015701127,0.00091738126,0.0015638411,0.00018960238,0.00005534006,1.4921294e-7,0.000005102993,0.00000960669,0.005860115,0.9858209],"study_design_scores_gemma":[0.012518082,0.013010712,0.00014904648,0.007116407,0.002078021,0.00054209767,0.000025986632,0.0000017987838,0.000007810004,0.00015253754,0.9641153,0.00028215986],"about_ca_topic_score_codex":0.000016430167,"about_ca_topic_score_gemma":0.00001737858,"teacher_disagreement_score":0.9855388,"about_ca_system_score_codex":0.000755434,"about_ca_system_score_gemma":0.009737429,"threshold_uncertainty_score":0.9999928},"labels":[],"label_agreement":null},{"id":"W2914899520","doi":"10.1111/ajco.13135","title":"Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival","year":2019,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Splenic flexure; Colorectal cancer; Hazard ratio; Internal medicine; Oncology; Primary tumor; Multivariate analysis; Chemotherapy; Proportional hazards model; Population; Cancer; Gastroenterology; Metastasis; Surgery; Confidence interval","score_opus":0.10361658283080687,"score_gpt":0.45146860513460185,"score_spread":0.34785202230379497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914899520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97064155,0.0010600418,0.000012087563,0.0022399728,0.006261938,0.00046405228,0.000020565594,0.000011701356,0.01928806],"genre_scores_gemma":[0.9960014,0.002206102,0.0010863288,0.00007776911,0.000294208,0.0000059890826,0.000004939826,0.00001961672,0.00030363238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951639,0.0008497591,0.0026760614,0.00038214566,0.0004980899,0.00043001017],"domain_scores_gemma":[0.99222463,0.0049969526,0.0018458266,0.0002274224,0.00043853602,0.00026663308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029926347,0.0002720497,0.0029107605,0.00022509671,0.000049578866,0.000008715109,0.00021968754,0.00029469212,0.0004404766],"category_scores_gemma":[0.0028247272,0.00019064518,0.0007145287,0.00021484596,0.0005229425,0.00013582963,0.00010030688,0.0011155065,0.000027539812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020332998,0.0019967295,0.9411355,0.000056662233,0.00095020625,0.0010269027,0.00072579074,0.000030188792,0.00031228006,0.0000916271,0.00042079267,0.032920297],"study_design_scores_gemma":[0.028569462,0.02599848,0.92972773,0.00031330853,0.0011444895,0.00018184696,0.0049497355,0.000077411394,0.00032579614,0.0003336796,0.008136326,0.00024171628],"about_ca_topic_score_codex":0.000082714956,"about_ca_topic_score_gemma":0.0015006531,"teacher_disagreement_score":0.03267858,"about_ca_system_score_codex":0.0004942057,"about_ca_system_score_gemma":0.0016026747,"threshold_uncertainty_score":0.7774285},"labels":[],"label_agreement":null},{"id":"W2920920710","doi":"10.1111/ajco.13116","title":"<i>BRCA</i> mutation testing for ovarian cancer in the context of available targeted therapy: Survey and consensus of Hong Kong specialists","year":2019,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Willow Breast and Hereditary Cancer Support","funders":"AstraZeneca","keywords":"Genetic testing; Medicine; Context (archaeology); Genetic counseling; Family medicine; BRCA mutation; Personalized medicine; Guideline; Delphi method; Breast cancer; Cancer; Bioinformatics; Internal medicine; Pathology; Genetics","score_opus":0.10005522970071315,"score_gpt":0.39378878930626904,"score_spread":0.2937335596055559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920920710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941402,0.0020942593,0.00009280552,0.000902746,0.00084235606,0.0003792793,0.000080331505,0.0000011184517,0.0014669165],"genre_scores_gemma":[0.9966265,0.00046647096,0.0022625267,0.00020622795,0.0003058295,0.0000084798285,0.00001577949,0.000014264423,0.00009390704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740547,0.0007416503,0.0013381381,0.00020270149,0.0001479321,0.00016411554],"domain_scores_gemma":[0.99527264,0.0023050983,0.0014290165,0.00019760738,0.00074886915,0.00004678252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044401884,0.000110066154,0.0005744625,0.00006396002,0.000027466136,0.000008308131,0.00020803028,0.00025456384,0.00003729557],"category_scores_gemma":[0.0023894855,0.000082532264,0.00012771296,0.00017223899,0.0002819322,0.0000067774395,0.000027310773,0.00023155363,9.87631e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034991226,0.00043148058,0.7815785,0.000053622352,0.0003762892,0.00001330124,0.00064681214,0.00024532448,0.102680184,0.000099363824,0.0084533775,0.10192267],"study_design_scores_gemma":[0.013846837,0.008846919,0.8831423,0.00011842431,0.00010438261,0.00018752718,0.0043979227,0.00030320854,0.045188587,0.00048083946,0.043078363,0.00030469114],"about_ca_topic_score_codex":0.00015201712,"about_ca_topic_score_gemma":0.0006590614,"teacher_disagreement_score":0.10161798,"about_ca_system_score_codex":0.000038864393,"about_ca_system_score_gemma":0.0013307674,"threshold_uncertainty_score":0.33655682},"labels":[],"label_agreement":null},{"id":"W2958441110","doi":"10.1111/ajco.13181","title":"Viable versus nonviable positive margins in Ewing sarcoma and associated recurrence rates: A systematic review","year":2019,"lang":"en","type":"review","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Margin (machine learning); Sarcoma; Surgical margin; Radiation therapy; Histology; Resection margin; Surgery; Soft tissue sarcoma; Radiology; Resection; Pathology","score_opus":0.19598565200160228,"score_gpt":0.49209004024854414,"score_spread":0.29610438824694185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958441110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000110929876,0.9905404,0.0000026427213,0.00081583165,0.0015706219,0.0030417477,0.00003237772,0.000008352627,0.0038771236],"genre_scores_gemma":[0.00060457713,0.99811184,0.00031253058,0.00028600966,0.00020689456,0.000102302016,0.000053278007,0.000055534383,0.00026702622],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9892442,0.0030998741,0.0060220305,0.00055988785,0.000529187,0.00054478477],"domain_scores_gemma":[0.9777479,0.01514841,0.0056814924,0.0005194525,0.00047332645,0.0004293916],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007414807,0.00058646075,0.014150934,0.00040099162,0.000051042713,0.000032880507,0.00032839904,0.0009457265,0.00007846978],"category_scores_gemma":[0.0103229005,0.00038492604,0.001630973,0.0006627897,0.0001640849,0.00014448832,0.00011661167,0.002161041,0.00013859327],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005756957,0.0046384763,0.0034355249,0.5828808,0.005457299,0.005864893,0.00008492844,1.4430132e-7,5.025599e-8,0.00007104779,0.0036914828,0.39329967],"study_design_scores_gemma":[0.0059598368,0.0055659004,0.0005971211,0.7578556,0.017697107,0.001918049,0.00017470773,0.0000049753703,1.4809211e-7,0.00001781992,0.20990771,0.0003010392],"about_ca_topic_score_codex":0.000016433169,"about_ca_topic_score_gemma":0.000015417034,"teacher_disagreement_score":0.3929986,"about_ca_system_score_codex":0.0010765158,"about_ca_system_score_gemma":0.0028047909,"threshold_uncertainty_score":0.9998603},"labels":[],"label_agreement":null},{"id":"W2971814790","doi":"10.1111/ajco.13234","title":"Impact of Asian ethnicity on outcome in metastatic EGFR‐mutant non–small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Brain metastasis; Lung cancer; Oncology; Univariate analysis; Cohort; Proportional hazards model; Cancer; Population; Metastasis; Multivariate analysis; Confidence interval","score_opus":0.07858565461785147,"score_gpt":0.5110388023357402,"score_spread":0.4324531477178887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971814790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96407217,0.00040899497,0.000072196555,0.0028540033,0.0011716463,0.0006142909,0.000029670568,0.0000057349175,0.030771287],"genre_scores_gemma":[0.996763,0.00039017704,0.0012160081,0.00027913088,0.00020841211,0.000009681345,0.0000051754614,0.000027171167,0.0011012801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99622154,0.00034757578,0.0024681285,0.00026606992,0.00034275008,0.00035391847],"domain_scores_gemma":[0.9963011,0.0010361945,0.0016669392,0.0003211036,0.00032228162,0.00035237859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015702315,0.0002250798,0.0019010768,0.00030115008,0.000021491489,0.0000068340687,0.00018289158,0.0002442438,0.00057550595],"category_scores_gemma":[0.00042686114,0.00014410308,0.00082419906,0.00029364362,0.00011484413,0.00009108687,0.000029511411,0.0010598864,0.000035274792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021875785,0.0031185674,0.9655446,0.00011201233,0.0010297742,0.0005112118,0.00075440656,0.00034817966,0.00067349686,0.00004062708,0.0007195495,0.02496],"study_design_scores_gemma":[0.015049743,0.014767703,0.96426505,0.0003185837,0.00133685,0.00014403558,0.0011093059,0.0002414199,0.00021746133,0.00009386558,0.0023034855,0.00015249105],"about_ca_topic_score_codex":0.00030589759,"about_ca_topic_score_gemma":0.00012663541,"teacher_disagreement_score":0.03269079,"about_ca_system_score_codex":0.0008389156,"about_ca_system_score_gemma":0.0031519758,"threshold_uncertainty_score":0.6301387},"labels":[],"label_agreement":null},{"id":"W2979495016","doi":"","title":"Community-Based Participatory Research in cancer control studies among Indigenous people of Australia, New Zealand, Canada and the US","year":2010,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Qualitative Research Methods and Ethics","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Indigenous; Participatory action research; Community-based participatory research; Citizen journalism; Geography; Socioeconomics; Control (management); Sociology; Environmental planning; Political science; Anthropology; Ecology; Economics; Management; Biology","score_opus":0.6888879500146597,"score_gpt":0.6759645624976514,"score_spread":0.012923387517008389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979495016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95345527,0.00038100057,0.000013347059,0.04470068,0.00073904305,0.00028555523,0.000008344725,0.0000016708841,0.00041507732],"genre_scores_gemma":[0.9974385,0.0011651105,0.0003426726,0.00019704962,0.0003776902,0.000013860203,2.6991052e-7,0.0000065364734,0.00045833935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9578948,0.038949113,0.0014718225,0.00012251576,0.0010010363,0.0005606991],"domain_scores_gemma":[0.93038106,0.06688009,0.0008239338,0.00020894928,0.0012583752,0.0004476068],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.12893178,0.00009385575,0.0010447089,0.00013554552,0.0004997018,0.00002469736,0.0005364897,0.0003159851,0.000048429625],"category_scores_gemma":[0.02635944,0.000059257924,0.00012747398,0.00041465936,0.0072457986,0.00009305559,0.00006273806,0.0052714827,7.390996e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00111427,0.0002777963,0.90890676,0.000034741566,0.00021504656,0.000046241814,0.069346964,0.000022771126,0.000023759345,0.0024148,0.0037789284,0.01381792],"study_design_scores_gemma":[0.009172357,0.0019746986,0.7395367,0.00014262395,0.000097740056,0.000004627558,0.1386658,0.000021433925,0.000030237987,0.027152462,0.083048314,0.00015299856],"about_ca_topic_score_codex":0.90588796,"about_ca_topic_score_gemma":0.9957243,"teacher_disagreement_score":0.16937006,"about_ca_system_score_codex":0.00021452496,"about_ca_system_score_gemma":0.015015043,"threshold_uncertainty_score":0.9970234},"labels":[],"label_agreement":null},{"id":"W3086232680","doi":"10.1111/ajco.13430","title":"Awareness of and preference for disease prognosis and participation in treatment decisions among advanced cancer patients in Myanmar: Results from the APPROACH study","year":2020,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Preference; Medicine; Disease; Descriptive statistics; Logistic regression; Cancer; Family medicine; Quarter (Canadian coin); Stage (stratigraphy); Internal medicine","score_opus":0.5958672120227494,"score_gpt":0.57180087968167,"score_spread":0.024066332341079355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086232680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878674,0.00071023114,0.00006466143,0.007968042,0.00023924645,0.0029017192,0.00019763933,0.0000047908966,0.000046236684],"genre_scores_gemma":[0.9960495,0.001283072,0.0016061818,0.00015222876,0.00008341717,0.0007815699,0.00002775265,0.000011862855,0.0000043629066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929571,0.0032078205,0.00304828,0.00032301495,0.0002228134,0.00024095307],"domain_scores_gemma":[0.9785917,0.018299256,0.0020075748,0.00029538103,0.0004795762,0.00032652973],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0012252177,0.00013488533,0.00082204444,0.00007087497,0.00016260755,0.0000050338317,0.00025956376,0.00017726167,0.0000037369732],"category_scores_gemma":[0.012524376,0.00008764371,0.000069916765,0.0002222144,0.00016815573,0.00015883891,0.00014230181,0.00060936745,3.782371e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054588313,0.0020000306,0.90914094,0.00003194147,0.000038955946,0.0000017226588,0.023038492,0.00007304361,7.1799525e-7,0.000016714095,0.000060957755,0.06013765],"study_design_scores_gemma":[0.010717521,0.003505568,0.95715547,0.00033576915,0.0000881897,5.081787e-8,0.02518372,0.002071718,0.0000011557764,0.0003768544,0.00049586716,0.00006810114],"about_ca_topic_score_codex":0.00083804247,"about_ca_topic_score_gemma":0.0037599104,"teacher_disagreement_score":0.06006955,"about_ca_system_score_codex":0.00017364982,"about_ca_system_score_gemma":0.0011832619,"threshold_uncertainty_score":0.9957935},"labels":[],"label_agreement":null},{"id":"W3092156640","doi":"10.1111/ajco.13482","title":"Changes in DNA methylation after 6‐week exercise training in colorectal cancer survivors: A preliminary study","year":2020,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging; University of Alberta","funders":"","keywords":"Epigenetics; DNA methylation; Colorectal cancer; Randomized controlled trial; Medicine; CpG site; Methylation; Disease; Oncology; Cancer; Internal medicine; Bioinformatics; Gene; Biology; Genetics; Gene expression","score_opus":0.08415892557546056,"score_gpt":0.3946346349472204,"score_spread":0.31047570937175983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092156640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938098,0.0022770315,0.00013666562,0.0023948597,0.0005822694,0.00037882422,0.0000060809357,0.0000034421637,0.0004110347],"genre_scores_gemma":[0.996809,0.0017985355,0.0004993933,0.000115374205,0.0006774622,0.000046048735,0.00000835736,0.000022618411,0.00002317505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969151,0.0008581795,0.0013966012,0.00034945112,0.0002110387,0.00026962318],"domain_scores_gemma":[0.99855715,0.00028926253,0.0006826551,0.000112425056,0.00016254975,0.00019593589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026477554,0.00017241247,0.0007538572,0.00014011715,0.000021136066,0.0000136212275,0.00020146322,0.00038891105,0.00003773147],"category_scores_gemma":[0.00091504114,0.00015545647,0.00015769014,0.00025608233,0.00008829088,0.000012795657,0.000083112755,0.0005064197,0.0000028343547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009164974,0.0015640014,0.62874204,0.000026027688,0.0001280548,0.00036701956,0.0076529183,0.0005946907,0.051455114,0.0000027731644,0.000066563865,0.30023584],"study_design_scores_gemma":[0.0061980314,0.02965076,0.91070616,0.000107958665,0.00013774,0.000012502435,0.013027255,0.0003974894,0.02887142,0.00022109145,0.010284627,0.0003849345],"about_ca_topic_score_codex":0.0000512128,"about_ca_topic_score_gemma":0.0042334315,"teacher_disagreement_score":0.29985088,"about_ca_system_score_codex":0.000042651205,"about_ca_system_score_gemma":0.0005327721,"threshold_uncertainty_score":0.63393307},"labels":[],"label_agreement":null},{"id":"W3129179205","doi":"10.1111/ajco.13508","title":"Measuring financial toxicity in Australian cancer patients – Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients","year":2021,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Quality of life (healthcare); Population; Cronbach's alpha; Anxiety; Depression (economics); Finance; Psychiatry; Environmental health; Psychometrics; Clinical psychology; Business; Nursing","score_opus":0.18885358239192773,"score_gpt":0.363324292670727,"score_spread":0.1744707102787993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129179205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882433,0.00038334474,0.00010636338,0.002456145,0.0061241672,0.0009930704,0.0008569096,0.000008223562,0.0008285018],"genre_scores_gemma":[0.9970342,0.0007141306,0.00027979165,0.0005519449,0.0010209775,0.00007684464,0.000020534933,0.00004318801,0.0002583992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925252,0.0003519463,0.0051250868,0.00077830243,0.00027210184,0.00094735454],"domain_scores_gemma":[0.99302095,0.0006207353,0.0045551267,0.0004112767,0.0010657223,0.0003262163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024886308,0.00047394997,0.0025998687,0.00038474955,0.00019228549,0.000058874168,0.00075295824,0.0009707361,0.00018196926],"category_scores_gemma":[0.007317928,0.0004744094,0.00090374757,0.0006807548,0.00035673194,0.00073683105,0.00018753002,0.0015166228,0.000010120507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013797712,0.0021242318,0.96715987,0.000118389224,0.00008029708,0.000018889674,0.00053138897,0.0016820062,0.00014304559,0.0010611798,0.0029805573,0.022720376],"study_design_scores_gemma":[0.0074630207,0.001080173,0.95208013,0.00043274416,0.000052402283,0.0000038018356,0.000087143904,0.000045524426,0.006756603,0.0038399915,0.027681004,0.00047745885],"about_ca_topic_score_codex":0.00082371675,"about_ca_topic_score_gemma":0.0070930566,"teacher_disagreement_score":0.024700448,"about_ca_system_score_codex":0.0018127053,"about_ca_system_score_gemma":0.0029038757,"threshold_uncertainty_score":0.99977076},"labels":[],"label_agreement":null},{"id":"W3133211858","doi":"10.1111/ajco.13544","title":"Australia and New Zealand's responsibilities in improving oncology services in the Asia‐Pacific: A call to action","year":2021,"lang":"en","type":"review","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Global Health and Surgery","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Call to action; Capacity building; Health care; Government (linguistics); Leverage (statistics); Public relations; Political science; Asia pacific; Business; Medicine; Marketing","score_opus":0.26987108053041253,"score_gpt":0.5416084245857075,"score_spread":0.2717373440552949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133211858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022665305,0.9349917,0.000006418587,0.03203184,0.004672142,0.0017750333,0.000023528832,0.00001700303,0.0038169895],"genre_scores_gemma":[0.0051314053,0.9874856,0.0009873777,0.0010480813,0.0019925223,0.000030370222,0.000028973815,0.000039811548,0.0032558802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9873352,0.004946649,0.0056499043,0.0006485473,0.0005329314,0.0008867411],"domain_scores_gemma":[0.9860922,0.009655415,0.0023471282,0.000527248,0.00032186264,0.0010561448],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.014694097,0.00048614392,0.006463428,0.0008034104,0.000057652036,0.000045936456,0.00039314615,0.0019457015,0.0000825113],"category_scores_gemma":[0.004577051,0.00030956816,0.0008955755,0.0008560052,0.00020268298,0.00014980065,0.00011961774,0.0043473495,0.000034121356],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020107008,0.0006648542,0.005101421,0.0029915983,0.00013154912,0.0043110205,0.00070783566,4.647463e-7,9.643463e-7,0.0000774919,0.018955128,0.96504694],"study_design_scores_gemma":[0.0020601938,0.0051507624,0.0074180886,0.0063930154,0.00050297205,0.006512398,0.0056736977,0.0000016343971,1.7517782e-7,0.00012475974,0.96594876,0.00021354143],"about_ca_topic_score_codex":0.0008804318,"about_ca_topic_score_gemma":0.0033358685,"teacher_disagreement_score":0.96483344,"about_ca_system_score_codex":0.00089557306,"about_ca_system_score_gemma":0.010923593,"threshold_uncertainty_score":0.9999356},"labels":[],"label_agreement":null},{"id":"W3173244755","doi":"10.1111/ajco.13595","title":"<sup>68</sup>Ga‐prostate‐specific membrane antigen (PSMA) PET/CT as a clinical decision‐making tool in biochemically recurrent prostate cancer","year":2021,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Sanofi; AstraZeneca; Pfizer; Astellas Pharma; Bristol-Myers Squibb","keywords":"Medicine; Watchful waiting; Prostate cancer; Biochemical recurrence; Logistic regression; Radiation therapy; Prostate; Radiology; Nuclear medicine; Urology; Internal medicine; Cancer; Prostatectomy","score_opus":0.09134584371318756,"score_gpt":0.4848521792671509,"score_spread":0.39350633555396336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173244755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96130645,0.016741361,0.00003081038,0.013972339,0.002459422,0.0009531669,0.000050462164,0.000036062916,0.0044499342],"genre_scores_gemma":[0.87233216,0.11648763,0.0072419723,0.000762321,0.0013916825,0.00005278585,0.00004686728,0.00008447436,0.0016000873],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9885081,0.0015373215,0.0062124063,0.0011455994,0.0014054703,0.0011911016],"domain_scores_gemma":[0.98959535,0.005324926,0.0017398627,0.0007958995,0.001695893,0.000848088],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0077729207,0.0005425135,0.003252944,0.00046883535,0.00014573405,0.00009608313,0.0005527626,0.00031892254,0.0015953579],"category_scores_gemma":[0.006742546,0.00040275365,0.0013364139,0.0011119329,0.0008865045,0.0002887147,0.00032095585,0.0038169567,0.00023252434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027646981,0.005849494,0.31942683,0.00015858652,0.001070405,0.06365287,0.00052181596,0.000059721056,0.0008076834,0.00011151666,0.019722108,0.560972],"study_design_scores_gemma":[0.051274944,0.017176647,0.116031736,0.005469954,0.0007433946,0.019617992,0.005152545,0.00060456863,0.0034147578,0.003827353,0.77552927,0.0011568248],"about_ca_topic_score_codex":0.000019099907,"about_ca_topic_score_gemma":0.000042150466,"teacher_disagreement_score":0.75580716,"about_ca_system_score_codex":0.00077843823,"about_ca_system_score_gemma":0.008869443,"threshold_uncertainty_score":0.9998424},"labels":[],"label_agreement":null},{"id":"W3214836900","doi":"10.1111/ajco.13700","title":"Poster Abstracts","year":2021,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Medical Research Council; Australian and New Zealand Urogenital and Prostate Cancer Trials Group; National Health and Medical Research Council; Peter MacCallum Cancer Centre; University of Melbourne","keywords":"Citation; Library science; Computer science; Information retrieval; World Wide Web","score_opus":0.09283884681477143,"score_gpt":0.4456423787686756,"score_spread":0.3528035319539041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214836900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7837322,0.0027783837,0.00004023366,0.04957735,0.0044814334,0.000110384266,0.0000036457843,0.000013185558,0.15926322],"genre_scores_gemma":[0.9876325,0.0017083312,0.0017100093,0.003510075,0.0014798302,8.2183044e-7,0.0000041348626,0.00001641152,0.0039378908],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99682623,0.00027740424,0.002186604,0.00017665995,0.0003002686,0.00023284317],"domain_scores_gemma":[0.9969648,0.00092839065,0.0010036984,0.0002475956,0.00055746804,0.0002980595],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002373114,0.00011797593,0.0009568814,0.00008130254,0.000032787404,0.000014649626,0.000116911935,0.00036213145,0.0010702678],"category_scores_gemma":[0.0012781775,0.00008656629,0.0007257368,0.00017015102,0.00020799032,0.00009015243,0.000028113385,0.000863143,0.000077149896],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019401034,0.0030780847,0.060238734,0.00005244916,0.0016849543,0.011667878,0.00029262708,0.0000014283098,0.013672664,0.00008898116,0.08345722,0.80636394],"study_design_scores_gemma":[0.0068136915,0.0038860687,0.2621549,0.00009806278,0.0001930154,0.0065217786,0.000617271,9.738964e-7,0.0027438358,0.00016440683,0.7167207,0.00008529162],"about_ca_topic_score_codex":0.000004102893,"about_ca_topic_score_gemma":0.000012447284,"teacher_disagreement_score":0.80627865,"about_ca_system_score_codex":0.00010059673,"about_ca_system_score_gemma":0.0022781163,"threshold_uncertainty_score":0.9998429},"labels":[],"label_agreement":null},{"id":"W4239232225","doi":"10.1111/ajco.12301","title":"International Speakers","year":2014,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"European Society for Medical Oncology; Monash University; Memorial Sloan-Kettering Cancer Center","keywords":"Linguistics; Psychology; Philosophy","score_opus":0.13853237616482456,"score_gpt":0.49714733523764176,"score_spread":0.3586149590728172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239232225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51572376,0.00015536272,0.0022664946,0.0468161,0.009025423,0.00013679909,0.0000029585526,0.000015178175,0.4258579],"genre_scores_gemma":[0.986537,0.00048614037,0.004238065,0.0009927555,0.0063668606,0.0000011286278,0.000004446403,0.000009941246,0.0013637061],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973824,0.00027576194,0.001593833,0.00016289052,0.00039633192,0.00018878633],"domain_scores_gemma":[0.99668664,0.0016231958,0.00086695264,0.00014826797,0.00041336904,0.00026160167],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027370085,0.00012124063,0.0009374993,0.00014452868,0.000041296735,0.0000057176676,0.00021144676,0.000046203586,0.0009519748],"category_scores_gemma":[0.003460647,0.00008285723,0.00037527012,0.000086262524,0.00030990268,0.000079471996,0.00007003115,0.00067614124,0.000056928533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001277927,0.000691627,0.3834147,0.000010116033,0.00077004696,0.00032269637,0.00018576701,0.000001691495,0.00013270132,0.0011629334,0.031003436,0.5810264],"study_design_scores_gemma":[0.004958673,0.00704585,0.18126872,0.00006301859,0.00016268846,0.0005622933,0.0013359238,0.00004339521,0.000052917516,0.000537468,0.8039084,0.000060636776],"about_ca_topic_score_codex":0.00000389039,"about_ca_topic_score_gemma":0.000005002228,"teacher_disagreement_score":0.772905,"about_ca_system_score_codex":0.00007116257,"about_ca_system_score_gemma":0.00021004038,"threshold_uncertainty_score":0.9999613},"labels":[],"label_agreement":null},{"id":"W4295992489","doi":"10.1111/ajco.12029","title":"Oral Abstracts","year":2012,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary; Baker Hughes (Canada); Alberta Health Services","funders":"Clinical Oncological Society of Australia; National Health Research Institutes; Sanofi","keywords":"Exhibition; Convention; Citation; Library science; Medicine; Political science; Psychology; History; Law; Computer science; Art history","score_opus":0.1403806078892433,"score_gpt":0.48173004100176114,"score_spread":0.34134943311251786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295992489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7918087,0.0018272635,0.00012988567,0.020152153,0.0075512095,0.00030358217,0.000004418203,0.000031285395,0.1781915],"genre_scores_gemma":[0.99031794,0.00092089357,0.002027438,0.0012174579,0.003827565,0.000003493551,0.0000022082274,0.000023797375,0.0016591861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962823,0.0003245798,0.002286141,0.0001584489,0.0004267381,0.0005218309],"domain_scores_gemma":[0.9953901,0.0016766671,0.0014581084,0.00018196694,0.0005888143,0.0007043005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004229194,0.0001841224,0.0013764586,0.00016650552,0.00006243558,0.0000073641127,0.0001249631,0.00039222327,0.00049664726],"category_scores_gemma":[0.004140219,0.00013464087,0.00055791414,0.00018902896,0.0003978752,0.00023655787,0.0000576446,0.0014603114,0.0003437765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048132963,0.0045263264,0.48374203,0.000036945883,0.001662486,0.00065041246,0.00050582073,0.0000034057412,0.00022587525,0.00018890113,0.13868828,0.36495623],"study_design_scores_gemma":[0.0048733647,0.005070593,0.51748407,0.000085397325,0.00054772606,0.0015924624,0.0011753188,0.000001819169,0.00014125211,0.00013574623,0.46878985,0.00010236998],"about_ca_topic_score_codex":0.0000058451187,"about_ca_topic_score_gemma":0.0000059072845,"teacher_disagreement_score":0.36485386,"about_ca_system_score_codex":0.0002209638,"about_ca_system_score_gemma":0.00078645314,"threshold_uncertainty_score":0.6344408},"labels":[],"label_agreement":null},{"id":"W4307496993","doi":"10.1111/ajco.13886","title":"Early phase oncology clinical trials in Malaysia: current status and future perspectives","year":2022,"lang":"en","type":"review","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Clinical trial; Drug development; Facilitator; Government (linguistics); Enabling; Clinical Oncology; Medicine; Oncology; Political science; Business; Economic growth; Internal medicine; Pharmacology; Drug; Cancer","score_opus":0.20695682958226733,"score_gpt":0.5511819430023001,"score_spread":0.3442251134200327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307496993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005486572,0.9825434,0.00003140915,0.0007330985,0.008649292,0.0007820519,0.0002112842,0.000004449429,0.0015584361],"genre_scores_gemma":[0.0006972879,0.9863009,0.0005621613,0.00010047682,0.012031032,0.000053782212,0.0001174939,0.00007216614,0.000064717315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97803086,0.010931038,0.009107019,0.0009595824,0.00032594247,0.0006455339],"domain_scores_gemma":[0.98153776,0.009431304,0.0074571427,0.0005588364,0.00026682633,0.00074813445],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.024697725,0.000578236,0.008331974,0.00037317706,0.00008191016,0.00004720372,0.00064712187,0.001962287,0.00023837405],"category_scores_gemma":[0.015189746,0.00046292634,0.0028583037,0.00027684803,0.00062537583,0.000011568843,0.00048380482,0.004159094,0.00000933186],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015179183,0.0028336812,0.00046129362,0.00030336995,0.0007914344,0.00034045122,0.00013109329,0.000001116521,0.000001527077,0.00021921929,0.007460511,0.9859384],"study_design_scores_gemma":[0.007094909,0.017223088,0.00023120358,0.00030689384,0.0013988774,0.0004147787,0.0014859461,0.000001581064,3.842071e-7,0.00013646376,0.97130513,0.0004007275],"about_ca_topic_score_codex":0.000008720777,"about_ca_topic_score_gemma":0.00003043833,"teacher_disagreement_score":0.98553765,"about_ca_system_score_codex":0.0003958705,"about_ca_system_score_gemma":0.008777594,"threshold_uncertainty_score":0.99978226},"labels":[],"label_agreement":null},{"id":"W4375950762","doi":"10.1111/ajco.13953","title":"18F‐FMISO PET‐guided dose escalation with multifield optimization intensity‐modulated proton therapy in nasopharyngeal carcinoma","year":2023,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Medical Research Council; Medical Research Council; Terry Fox Foundation; National Cancer Centre of Singapore","keywords":"Nuclear medicine; Medicine; Radiation therapy; Proton therapy; Positron emission tomography; Radiation treatment planning; Tumor hypoxia; Standardized uptake value; Radiology","score_opus":0.08901909957813778,"score_gpt":0.4094858639795292,"score_spread":0.32046676440139144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375950762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98584366,0.00012497691,0.0006568173,0.010076947,0.0008140532,0.00090058876,0.0000016506846,0.00005321717,0.0015280709],"genre_scores_gemma":[0.99476844,0.00065986975,0.002904963,0.0006509053,0.0005532123,0.000017494605,0.000035145687,0.000032888427,0.00037705142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652636,0.0005009957,0.0019606731,0.00030201976,0.0004066757,0.00030325807],"domain_scores_gemma":[0.9970449,0.0007849032,0.0010869988,0.00026316507,0.00054479466,0.00027520547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026866347,0.0002017682,0.0011044508,0.00055390276,0.00006135224,0.00001975486,0.00014561112,0.0003252246,0.00017643497],"category_scores_gemma":[0.0009265638,0.00014639413,0.0002520264,0.0009054818,0.0001662396,0.00022540546,0.000019738665,0.0009912913,0.000027068227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031178363,0.0021738398,0.85519916,0.00005493819,0.0004654553,0.0033577788,0.0010687233,0.015411863,0.0015927574,0.00003905753,0.00294186,0.08651622],"study_design_scores_gemma":[0.030710587,0.017157685,0.8762927,0.00018305902,0.00013180381,0.0017000983,0.0010247453,0.06534199,0.0019231505,0.00022070993,0.005022982,0.00029050346],"about_ca_topic_score_codex":0.000021475716,"about_ca_topic_score_gemma":0.000007722867,"teacher_disagreement_score":0.08622571,"about_ca_system_score_codex":0.00014203867,"about_ca_system_score_gemma":0.00076524005,"threshold_uncertainty_score":0.59697795},"labels":[],"label_agreement":null},{"id":"W4387296889","doi":"10.1111/ajco.14030","title":"Re‐re‐biopsy? How much tumor is enough in the era of precision oncology?","year":2023,"lang":"en","type":"editorial","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Liquid biopsy; Erlotinib; Afatinib; Medicine; Precision medicine; Gefitinib; Cancer research; Lung cancer; Personalized medicine; Epidermal growth factor receptor; Targeted therapy; Oncology; Mutation; Biopsy; ROS1; Internal medicine; Cancer; Gene; Pathology; Bioinformatics; Adenocarcinoma; Biology; Genetics","score_opus":0.07119682710064731,"score_gpt":0.49022388508803566,"score_spread":0.4190270579873884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387296889","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009055743,0.0014629777,0.000027357557,0.09529772,0.86973727,0.0010644897,0.00024543647,0.00002601594,0.023082977],"genre_scores_gemma":[0.14368767,0.010608041,0.004300575,0.0012163079,0.8338247,0.000095224044,0.0002805791,0.00017765707,0.00580924],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99204654,0.0014869488,0.0038440465,0.0005719899,0.0015054155,0.00054508547],"domain_scores_gemma":[0.9683043,0.024659824,0.0045150006,0.0007532941,0.0014240753,0.0003435471],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.007420599,0.00043892453,0.0034674008,0.00037652813,0.000093468276,0.00003288278,0.0007654589,0.0021481935,0.0002336413],"category_scores_gemma":[0.01611001,0.0002652579,0.0011752072,0.00063037477,0.00052419136,0.00014429871,0.00011400058,0.0057143853,0.00006605032],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027294941,0.0023674497,0.0008181467,0.00009787596,0.0009842895,0.003207302,0.0023028697,0.0000015789068,0.000011959557,0.000022255921,0.9241776,0.06327917],"study_design_scores_gemma":[0.009328029,0.01631545,0.0027146586,0.0008204682,0.0018807956,0.00021764237,0.009304082,0.0000059278523,0.000018207289,0.0006936307,0.9585101,0.00019101545],"about_ca_topic_score_codex":0.00008582091,"about_ca_topic_score_gemma":0.0002048225,"teacher_disagreement_score":0.13463193,"about_ca_system_score_codex":0.0008526237,"about_ca_system_score_gemma":0.010423885,"threshold_uncertainty_score":0.99998},"labels":[],"label_agreement":null},{"id":"W4394873139","doi":"10.1111/ajco.14064","title":"Management of advanced prostate cancer in the Asia‐Pacific region: Summary of the Asia‐Pacific Advanced Prostate Cancer Consensus Conference 2023","year":2024,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Astellas Pharma Canada; Bayer; AstraZeneca; Pfizer","keywords":"Prostate cancer; Consensus conference; Reimbursement; Asia pacific; Medicine; Cancer; Political science; Gynecology; Internal medicine; Business; Health care","score_opus":0.08370714508975953,"score_gpt":0.4454766813636823,"score_spread":0.3617695362739228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394873139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62305146,0.06862987,0.000025217656,0.21779066,0.007872353,0.006333654,0.00042983412,0.00006500817,0.07580196],"genre_scores_gemma":[0.9102684,0.06387193,0.0004030379,0.00009796453,0.00033734797,0.0002378328,0.00001492153,0.00005908052,0.024709467],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992715,0.0012079282,0.0032645322,0.0007120471,0.0012395039,0.000860991],"domain_scores_gemma":[0.99437857,0.0017000654,0.0017576033,0.00084689795,0.0009869251,0.00032994463],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034830861,0.00048317897,0.0019597406,0.00038038415,0.00013295097,0.00004563884,0.00076250976,0.00039154012,0.00018251245],"category_scores_gemma":[0.00033626362,0.00026680113,0.00076188636,0.0014405898,0.001774737,0.0002107744,0.00019740037,0.0022178453,0.000012939617],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032011263,0.003092465,0.0766758,0.0029303804,0.0036306644,0.0102221025,0.0062923254,0.0004886973,0.0030247923,0.0029792055,0.057336044,0.80131626],"study_design_scores_gemma":[0.027587248,0.012471015,0.124846175,0.014744693,0.002123736,0.001382065,0.08639491,0.00039320986,0.004367944,0.004368757,0.7204288,0.0008914039],"about_ca_topic_score_codex":0.00006710548,"about_ca_topic_score_gemma":0.00014724767,"teacher_disagreement_score":0.8004249,"about_ca_system_score_codex":0.0005689719,"about_ca_system_score_gemma":0.0040903813,"threshold_uncertainty_score":0.9999784},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"}]}